Stephen S. Yoder
2023
In 2023, Stephen S. Yoder earned a total compensation of $1.4M as Chief Executive Officer at Pieris Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Bonus | $146,149 |
|---|---|
| Option Awards | $614,818 |
| Salary | $584,595 |
| Other | $13,390 |
| Total | $1,358,952 |
Yoder received $614.8K in option awards, accounting for 45% of the total pay in 2023.
Yoder also received $146.1K in bonus, $584.6K in salary and $13.4K in other compensation.
Rankings
In 2023, Stephen S. Yoder's compensation ranked 862nd out of 2,816 executives tracked by ExecPay. In other words, Yoder earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 862 out of 2,816 | 69th |
Division Manufacturing | 510 out of 1,551 | 67th |
Major group Chemicals And Allied Products | 350 out of 877 | 60th |
Industry group Drugs | 340 out of 840 | 60th |
Industry Pharmaceutical Preparations | 231 out of 605 | 62nd |
Source: SEC filing on November 6, 2024.
Yoder's colleagues
We found two more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2023.